PRICE T ROWE ASSOCIATES INC /MD/ - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 56 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$47,401
+6.6%
3,000,037
+2.1%
0.01%
+16.7%
Q2 2023$44,487
+2.8%
2,938,308
-1.5%
0.01%0.0%
Q1 2023$43,267
+6.2%
2,983,863
-1.0%
0.01%
-14.3%
Q4 2022$40,754
-99.9%
3,014,377
+1.4%
0.01%
-12.5%
Q3 2022$46,840,000
+57.8%
2,972,050
+21.9%
0.01%
+100.0%
Q2 2022$29,689,000
+26.7%
2,437,498
-2.3%
0.00%
+100.0%
Q1 2022$23,425,000
-32.3%
2,494,714
+23.5%
0.00%
-33.3%
Q4 2021$34,593,0002,020,6370.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$8,042,56353.88%
MPM ASSET MANAGEMENT LLC 4,425,784$69,927,38737.45%
5AM Venture Management, LLC 4,408,379$69,652,38820.04%
StepStone Group LP 761,277$12,028,1772.68%
TCG Crossover Management, LLC 584,955$9,242,2891.36%
Redmile Group, LLC 1,284,000$20,287,2000.96%
Nan Fung Group Holdings Ltd 49,082$775,4960.63%
Baker Brothers Advisors 4,865,819$76,879,9400.44%
Corton Capital Inc. 10,485$165,6630.08%
CORNERCAP INVESTMENT COUNSEL INC 13,977$220,8370.04%
View complete list of ENTRADA THERAPEUTICS INC shareholders